mPhase/AlwaysReady to Present at Medi 2008 Conference
Leading microfluidics and nanotechnology development company mPhase Technologies, Inc. (OTCBB: XDSL) today announced that it will be presenting a paper titled “Wetting the Surface from Self Cleaning Leaves to Energy Storage Devices” at MEDI 2008, September 9-10, 2008, at the Connecticut Convention Center in Hartford, Connecticut. This event brings together leaders in the medical device and bionanotechnology industry.
Steve Simon, the Chief Technology officer of AlwaysReady, will describe how interactions observed in nature at the micro and nano scales “mimic” some of the technical design elements of the scientific proprieties underling the revolutionary Smart NanoBattery.
Said AlwaysReady CTO Steve Simon, “We are very pleased to have the opportunity to share our work at this venue and to expose our work to leading members of the medical and bionanotechnology community designing leading edge technologies in these fields. Future potential applications in the medical device and bionanotechnology industries will also be discussed.”
About mPhase Technologies, Inc. and AlwaysReady, Inc.
mPhase Technologies, Inc. (OTCBB: XDSL) is a U.S. based microfluidic and nanotechnology specialist. Through its wholly owned subsidiary AlwaysReady, Inc., mPhase is focused on developing and commercializing its first nanotechnology based product the Smart NanoBattery. This new battery technology is based on a well-patented phenomenon known as electrowetting, which provides a unique way to store energy and manage power that will revolutionize the battery industry. For more information please visit our website at www.mPhaseTech.com.
Safe Harbor Statement
This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of companies mentioned in this press release in light of current conditions, expected future developments and other factors they believe to be appropriate. Actual results may differ as a result of factors over which the company has no control.
Contact: Mr. Gerard Adams mPhase Technologies, Inc. Investor Relations 973-256-3737 x105 Email Contact
SOURCE: mPhase Technologies